Dare Net Working Capital from 2010 to 2026
| DARE Stock | USD 1.95 0.02 1.02% |
Net Working Capital | First Reported 2020-03-31 | Previous Quarter -12.6 M | Current Value 3.8 M | Quarterly Volatility 14.9 M |
Check Dare Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dare Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.2 K, Interest Expense of 528.6 M or Total Revenue of 10.7 K, as well as many indicators such as Price To Sales Ratio of 2.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 11.8 K. Dare financial statements analysis is a perfect complement when working with Dare Bioscience Valuation or Volatility modules.
Dare | Net Working Capital | Build AI portfolio with Dare Stock |
Latest Dare Bioscience's Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Dare Bioscience over the last few years. It is Dare Bioscience's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dare Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Net Working Capital | 10 Years Trend |
|
Net Working Capital |
| Timeline |
Dare Net Working Capital Regression Statistics
| Arithmetic Mean | 6,139,744 | |
| Coefficient Of Variation | 159.71 | |
| Mean Deviation | 5,685,822 | |
| Median | 7,382,465 | |
| Standard Deviation | 9,805,824 | |
| Sample Variance | 96.2T | |
| Range | 42.4M | |
| R-Value | (0.22) | |
| Mean Square Error | 97.4T | |
| R-Squared | 0.05 | |
| Significance | 0.39 | |
| Slope | (436,497) | |
| Total Sum of Squares | 1538.5T |
Dare Net Working Capital History
About Dare Bioscience Financial Statements
Dare Bioscience stakeholders use historical fundamental indicators, such as Dare Bioscience's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Dare Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Dare Bioscience's assets and liabilities are reflected in the revenues and expenses on Dare Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Dare Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | -2.8 M | -2.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dare Bioscience is a strong investment it is important to analyze Dare Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Dare Bioscience's future performance. For an informed investment choice regarding Dare Stock, refer to the following important reports:Check out the analysis of Dare Bioscience Correlation against competitors. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.